DANAZOL

被引：95

作者：

MADANES, AE

FARBER, M

机构：

[1] TUFTS UNIV, SCH MED, DEPT INTERNAL MED, MEDFORD, MA 02155 USA

[2] TUFTS UNIV, NEW ENGLAND MED CTR, BOSTON, MA 02111 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1982年 / 96卷 / 05期

关键词：

D O I：

10.7326/0003-4819-96-5-625

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：625 / 630

页数：6

共 92 条

[1]

ANDREWS MC, 1975, AM J OBSTET GYNECOL, V121, P817

[2] ENOVID THERAPY (NORETHYNODREL WITH MESTRANOL) FOR FIBROCYSTIC DISEASE [J].

ARIEL, IM .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (04) :453-459

[3] USE OF AN IMPEDED ANDROGEN-DANAZOL-IN MANAGEMENT OF BENIGN BREAST DISORDERS [J].

ASCH, RH ;

GREENBLATT, RB .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1977, 127 (02) :130-134

[4]

ASCH RH, 1979, OBSTET GYNECOL, V53, P415

[5]

Atkins HJB, 1940, LANCET, V2, P411

[6]

AUDEBERT AJM, 1979, POSTGRAD MED J, V55, P10

[7]

BARBIERI RL, 1979, FERTIL STERIL, V31, P182

[8] DANAZOL INHIBITS HUMAN ADRENAL 21-HYDROXYLATION AND 11-BETA-HYDROXYLATION INVITRO [J].

BARBIERI, RL ;

OSATHANONDH, R ;

CANICK, JA ;

STILLMAN, RJ ;

RYAN, KJ .

STEROIDS, 1980, 35 (03) :251-263

[9] DOSAGE ASPECTS OF DANAZOL THERAPY IN ENDOMETRIOSIS - SHORT-TERM AND LONG-TERM EFFECTIVENESS [J].

BIBEROGLU, KO ;

BEHRMAN, SJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 139 (06) :645-654

[10]

BLACKMORE WP, 1977, J INT MED RES, V5, P101

← 1 2 3 4 5 6 7 8 9 10 →